Android app Apple app link

Greenhaven Road Capital's Updates on Lifecore Biomedical (LFCR)

By Yahoo! Finance   |   1 month ago
Greenhaven Road Capital's Updates on Lifecore Biomedical (LFCR)

Greenhaven Road Capital's Q4 2024 investor letter highlights a 13% return for the quarter, totaling 27% for the year. They spotlight Lifecore Biomedical, Inc.

Read More

Did you find this insightful?

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

To become a member, please download and purchase membership through our app.